Understanding blood cancers requires not only deep scientific knowledge but also compassionate, personalized care, a philosophy embraced by the best onco-hematologists in the United Arab Emirates. These specialists are highly regarded for their expertise in diagnosing and treating complex blood disorders such as leukemia, lymphoma, multiple myeloma, and other hematologic malignancies. Known for their clinical precision and patient-first mindset, they have become trusted names for both residents and international patients seeking advanced cancer care.
The leading onco-hematologists in the UAE combine extensive training with the latest innovations in hematology and oncology. Many have completed fellowships or advanced programs in Europe or North America and continue to participate in global research and clinical trials. This commitment to staying ahead of medical advancements allows them to offer advanced treatments, including targeted therapies, bone marrow transplantation, and immunotherapy.
Most of these top Onco-Hematologists practice in internationally accredited hospitals and cancer centers across Dubai, Abu Dhabi, and Sharjah institutions that are equipped with advanced technology and multidisciplinary teams. Their memberships in global professional societies and active participation in regional and international medical forums reflect their dedication to continuous learning and excellence in care.
Patients choose the best onco-hematologists in the UAE not only for their technical skill, but for their compassionate and communicative approach. They ensure that each patient feels supported, informed, and empowered throughout their treatment journey. From the first diagnosis to survivorship care, these specialists are known for offering hope, clarity, and world-class medical support every step of the way.
Dr. Ajlan Al Zaki
Specializations: Hematologic malignancies, CAR T cell therapy, immunotherapy
Experience: Over 20 years
Dr. Ajlan Al Zaki is a UAE national and triple Board Certified Hematologist Oncologist who directs the Burjeel Hematology Oncology and Cellular Therapy Center in Abu Dhabi. He specializes in cutting-edge cellular therapies, including CAR T cell treatment for complex blood cancers like leukemia, lymphoma, multiple myeloma, MDS, and MPNs. With two decades of combined clinical and research experience in leading US institutions such as Stanford and MD Anderson, he brings personalized care informed by rigorous academic training. He also leads multiple clinical trials and research initiatives in immunotherapy and molecular imaging, while offering compassionate, patient-focused care at one of the region’s most advanced cancer centers.
Dr. Mohamad Azzam Ziade
Specializations: Leukemia, lymphoma, multiple myeloma, bone marrow transplantation
Experience: Over 25 years
Dr. Mohamad Azzam Ziade is a distinguished Consultant Oncologist and Hematologist practicing across Dubai, Sharjah, and Abu Dhabi. He holds degrees in Medical Oncology, European Bone Marrow Transplant certification, and training from institutions including King’s College Hospital in London, University of Padova, and the Mediterranean Institute of Hematology. His broad expertise covers malignant and benign hematologic disorders, hemoglobinopathies, and solid tumors. Dr. Ziade is recognized for his leadership in bone marrow transplantation and his multilingual, culturally sensitive approach to patient care across the UAE.
Dr. Abdel Rahman Labban
Specializations: Hematology Oncology of leukemia, lymphoma, myeloma, benign and malignant blood disorders
Experience: Over 16 years
Dr. Abdel Rahman Labban is a highly experienced Medical Oncology and Hematology Specialist based at Burjeel Dubai. He completed his sub-specialty training in Beirut and further advanced studies in Brussels, enhancing his expertise in hematologic malignancies, chemotherapy, immunotherapy, and targeted therapies. He is well-versed in treating both solid tumors and complex blood diseases, including myelodysplastic syndromes and coagulation disorders. Dr. Labban is also active in clinical education, public awareness campaigns and is fluent in English, Arabic, and French.
Dr. Husni Al Hateeti
Specializations: Lymphoma, rare hematologic disorders, benign hematology
Experience: Over 25 years
Dr. Husni Al Hateeti is a Consultant in Haematology and Oncology at Sheikh Shakhbout Medical City in Abu Dhabi, with more than 30 years in the field, including leadership experience at Sheikh Khalifa Medical City. He is well known for treating lymphoma and rare blood disorders such as HLH, PNH, TTP/HUS, Gaucher disease, and beta‑thalassemia. Dr. Hateeti has participated as a lead investigator in international multi‑centre clinical trials and has multiple publications in regional medical journals. His deep experience and focus on uncommon hematologic conditions make him a highly respected figure in UAE cancer care. He communicates fluently in Arabic and English.
Dr. Faraz A. Khan
Specializations: Hematologic malignancies, solid tumors, benign hematology
Experience: Over 15 years
Dr. Faraz A. Khan is a Consultant Hematologist and Medical Oncologist at the American Hospital Dubai, with triple board certification in Internal Medicine, Hematology, and Medical Oncology from the University of Connecticut, USA. He has previously served as a consultant in Canada and directed a provincial hemophilia and bleeding disorders clinic. Dr. Khan treats lymphomas, leukemias, myeloma, as well as benign blood conditions and solid tumors, including breast, colon, lung, and gastrointestinal cancers. He is active in the Emirates Society of Hematology and ASCO, known for his expert, patient‑focused approach.
Consultations with Hematologist-Oncologists | $350 |
Consultations with a Hematologist | $350 |
Note: The consultation fees of Onco-Hematologists in the United Arab Emirates are generally considered competitive, especially given the high standard of care and advanced medical infrastructure available in the country. While costs can vary depending on the condition, required procedures, and hospital, patients often find that the value and quality of care justify the investment. Many leading hospitals also provide transparent pricing and comprehensive support services for international patients.
➤ Internationally Trained Experts with 15–30 Years of Clinical Experience
➤ Leading Specialists in Treating Leukemia, Lymphoma, Myeloma, and Rare Blood Disorders
➤ Skilled in Advanced Therapies Including CAR T Cell Therapy, Immunotherapy, and Bone Marrow Transplants
➤ Board Certified in Hematology and Oncology from the US, UK, Canada, and Europe
➤ Practice in JCI-Accredited Hospitals with World-Class Facilities
➤ Multilingual Care Teams Offering Personalized and Culturally Sensitive Support
➤ Transparent and Competitive Consultation Fees with No Hidden Costs
➤ Trusted by Both Local and International Patients for Compassionate, Outcome-Driven Care